Published: 30 June 2012
  • Seroconversion is the period of time during which HIV antibodies develop and become detectable.
  • Seroconversion generally takes place within a few weeks of initial infection.
  • It is often, but not always, accompanied by flu-like symptoms including fever, rash, muscle aches and swollen lymph nodes. These symptoms are not a reliable way to identify seroconversion or to diagnose HIV infection.

Seroconversion is the interval, several weeks after HIV infection, during which antibodies are first produced and rise to detectable levels. Antibodies generally begin to appear within one to two weeks of exposure, and antibody concentrations (titres) continue to increase for several months thereafter. Seroconversion takes place within three weeks in most infected individuals, although very rare cases are reported in which seroconversion does not occur for up to a year.1

Seroconversion is often – although not always – accompanied by a flare of symptoms called seroconversion illness (sometimes also called acute retroviral syndrome). Symptomatic seroconversion illness occurs in at least 50%, and possibly as many as 80 or 90%, of infected individuals.

When symptoms are present, they are usually 'flu-like' in nature, typically including any one or more of: fever, rash, swollen lymph nodes, muscle aches and joint pains. Less commonly, symptoms may also include headache, sore throat, diarrhoea or other gastrointestinal upsets, ulcers of the oesophagus, anus and/or vagina, oral candidiasis, and central nervous system disorders including encephalitis and meningitis. There are often abnormalities in laboratory values during seroconversion, including increased levels of inflammatory cytokines (indicating immune activation) and a short-term decrease in lymphocytes (white blood cells), followed by an increase in CD8+ cells and overall lymphocytes.

These symptoms typically begin one to four weeks after infection and almost always resolve within two to three weeks, although the swollen lymph nodes, tiredness and malaise can persist much longer. Since most symptoms are so non-specific (except for the reddish, macular (small, flat blemishes), non-itchy rash, which may provide a distinctive sign for an experienced clinician), and may not be present at all, they may easily be missed or misattributed to a flu or other viral infection.

At this stage, people are extremely infectious, and this issue is dealt with in a previous section.

The interval after infection, but prior to seroconversion, is called the window period. 2 3

Tell us why you visited aidsmap today

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?


Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email


  1. Morpeth SC et al. Time to HIV-1 seroconversion similar among patients with acute HIV-1 infection; but there are exceptions… Thirteenth Conference on Retroviruses and Opportunistic Infections, Denver, poster 389, 2006
  2. Pillay D and Fisher M Primary HIV infection, phylogenetics, and antiretroviral prevention. J Infect Dis 195: 924-26, 2007
  3. Levy JA HIV and the pathogenesis of AIDS, Third edition. Washington: ASM Press, 2007
This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.